Test group:Takeing Artequick

2 trials

Sponsors

Guangzhou University of Chinese Medicine

Conditions

Malaria

Phase 4

A Randomized, Single-blind, Multi-center Clinical Study for Artemisinin-Piperazine and Artemether-Benzolol in the Treatment of Uncomplicated Falciparum Malaria

Active, not recruitingITMCTR1900002588

Guangzhou University of Chinese MedicineMalaria

Start: 2019-10-01Updated: 2023-02-20

A Randomized, Single-blind, Multi-center Clinical Study for Artemisinin-Piperazine and Artemether-Benzolol in the Treatment of Uncomplicated Falciparum Malaria

Active, not recruitingChiCTR1900025860

Guangzhou University of Chinese MedicineMalaria

Start: 2019-10-01Updated: 2019-09-16